PureTech, a cross-disciplinary healthcase company founded by the distinguished bioengineer Dr. Robert Langer, recently launched two two companies.

Vor BioPharma is an immuno-oncology company dedicated to developing a new class of targeted cell therapies to treat highly fatal malignancies. The company is advancing a novel approach to chimeric antigen receptor (CAR) T-cell therapy that has the potential to broaden its applicability and success rate in other cancers … more

Alivio Therapeutics is developing a novel technology for the targeted treatment of chronic and acute inflammatory disorders. Alivio is advancing its proprietary hydrogel technology, which  is designed to adhere to inflamed tissue and delivers medication based on the levels of inflammation, potentially enabling improved properties while minimizing exposure to healthy tissue and other systemic side effects … more